These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35581554)

  • 1. Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India.
    Kausalya B; Saravanan S; Pallikkuth S; Pahwa R; Saini SR; Iqbal S; Solomon S; Murugavel KG; Poongulali S; Kumarasamy N; Pahwa S
    BMC Immunol; 2022 May; 23(1):24. PubMed ID: 35581554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.
    Marchetti G; Cozzi-Lepri A; Tincati C; Calcagno A; Ceccherini-Silberstein F; De Luca A; Antinori A; Castagna A; Puoti M; Monforte Ad;
    BMC Infect Dis; 2014 Feb; 14():79. PubMed ID: 24520976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection.
    Zanni MV; Toribio M; Robbins GK; Burdo TH; Lu MT; Ishai AE; Feldpausch MN; Martin A; Melbourne K; Triant VA; Suchindran S; Lee H; Hoffmann U; Williams KC; Tawakol A; Grinspoon SK
    JAMA Cardiol; 2016 Jul; 1(4):474-80. PubMed ID: 27438325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.
    Ho JE; Deeks SG; Hecht FM; Xie Y; Schnell A; Martin JN; Ganz P; Hsue PY
    AIDS; 2010 Jul; 24(12):1897-905. PubMed ID: 20543654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
    Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
    PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults.
    Zhang Z; Chew GM; Shikuma CM; Gangcuangco LMA; Souza SA; Shiramizu B; Nakamoto BK; Gong T; Mannem SR; Mitchell BI; Kallianpur KJ; Ndhlovu LC; Chow DC
    HIV Clin Trials; 2018 Oct; 19(5):172-176. PubMed ID: 30422099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study.
    Hileman CO; Carman TL; Longenecker CT; Labbato DE; Storer NJ; White CA; McComsey GA
    Antivir Ther; 2013; 18(7):921-9. PubMed ID: 23756436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma CD16
    Marques de Menezes EG; Deng X; Liu J; Bowler SA; Shikuma CM; Stone M; Hunt PW; Ndhlovu LC; Norris PJ
    mBio; 2022 Jun; 13(3):e0300521. PubMed ID: 35435733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.
    Diaz CM; Segura ER; Luz PM; Clark JL; Ribeiro SR; De Boni R; Eksterman L; Moreira R; Currier JS; Veloso VG; Grinsztejn B; Lake JE
    BMC Infect Dis; 2016 Aug; 16():376. PubMed ID: 27503230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery.
    Serrano-Villar S; Moreno S; Fuentes-Ferrer M; Sánchez-Marcos C; Avila M; Sainz T; de Villar NG; Fernández-Cruz A; Estrada V
    HIV Med; 2014 Jan; 15(1):40-9. PubMed ID: 24007533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans.
    Fourie CM; Schutte AE; Smith W; Kruger A; van Rooyen JM
    Atherosclerosis; 2015 May; 240(1):154-60. PubMed ID: 25795556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.
    Pallikkuth S; Pahwa R; Kausalya B; Saravanan S; Pan L; Vignesh R; Iqbal S; Solomon SS; Murugavel KG; Poongulali S; Kumarasamy N; Pahwa S
    PLoS One; 2018; 13(10):e0206256. PubMed ID: 30379878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.
    Muenchhoff M; Healy M; Singh R; Roider J; Groll A; Kindra C; Sibaya T; Moonsamy A; McGregor C; Phan MQ; Palma A; Kloverpris H; Leslie A; Bobat R; LaRussa P; Ndung'u T; Goulder P; Sobieszczyk ME; Archary M
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):46-55. PubMed ID: 28670966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve men.
    Luo L; Han Y; Song X; Zhu T; Zeng Y; Li T
    HIV Clin Trials; 2018 Apr; 19(2):39-45. PubMed ID: 29770747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.
    Vos AG; Dodd CN; Delemarre EM; Nierkens S; Serenata C; Grobbee DE; Klipstein-Grobusch K; Venter WDF
    Front Immunol; 2021; 12():647805. PubMed ID: 34290695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease Burden in Rural Africa: Does HIV and Antiretroviral Treatment Play a Role?: Baseline Analysis of the Ndlovu Cohort Study.
    Vos AG; Barth RE; Klipstein-Grobusch K; Tempelman HA; Devillé WLJ; Dodd C; Coutinho RA; Grobbee DE;
    J Am Heart Assoc; 2020 Apr; 9(7):e013466. PubMed ID: 32223395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study.
    Martínez-Ayala P; Alanis-Sánchez GA; González-Hernández LA; Álvarez-Zavala M; Cabrera-Silva RI; Andrade-Villanueva JF; Sánchez-Reyes K; Ramos-Solano M; Castañeda-Zaragoza DA; Cardona-Müller D; Totsuka-Sutto S; Cardona-Muñoz E; Ramos-Becerra CG
    BMC Cardiovasc Disord; 2020 Oct; 20(1):440. PubMed ID: 33028211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.